Freezing early stage breast tumors gives women new nonsurgical treatment option
OGDEN, UTAH (June 8, 2016) - Women with early stage breast tumors now have a safe and effective nonsurgical treatment available to them in northern Utah.
We take a proactive approach to women’s health and well-being,” said Jose Perez Tomayo, M.D., diagnostic radiologist. “Being the first hospital in Utah to offer an effective alternative treatment for early stage breast cancer underscores our commitment to providing the highest level of patient care.”
Breast tumors are areas where cells have grown abnormally and rapidly. Physicians may recommend surgery to remove the tumor, depending on its type and size. Cryoablation offers an alternative to surgery when appropriate for the patient. The breast is an ideal location for this treatment because it is easy to access tumors and there are no internal organs between the technology and the ablation site.
This innovative alternative to treating early stage breast cancer provides numerous benefits. The procedure is performed under local anesthesia in about 30 minutes or less. It does not involve tissue removal, which maintains the breast’s shape and results in minimal visible scarring – if any. Most patients report minimal discomfort and are able to resume normal activity right away.
“We encourage our patients to understand their options and make informed treatment decisions,” Tamayo continues. “Cryoablation is a great choice for women diagnosed with early stage breast tumors. We see positive results following this virtually painless, in-office procedure. It is a safe and effective treatment that can reduce the stress that is often related to a breast cancer diagnosis.”
Cryoablation is FDA approved for the ablation of cancerous or malignant tissue and benign tumors. The technology destroys tumors by freezing them with liquid nitrogen and damaging the adjacent vasculature that fuels tumor growth. It is a safe and effective option for women whose breast tumor is less than 4 cm in diameter, visible on sonogram and has been confirmed with a biopsy.
To perform the procedure, physicians pass a hollow-tipped probe through a small incision and insert it into the breast. They use ultrasound imaging to help guide the probe into the center of the tumor. Low-pressure liquid nitrogen is inserted through the probe and forms an ice ball around the treatment area. The cancer cells are destroyed after several freeze-thaw cycles and the surrounding healthy tissue is left intact. The dead cells are gradually reabsorbed and expelled by the body over a period of 3-18 months. Ogden Regional Medical Center implemented the Visica 2 Treatment System, developed by Sanarus Technologies, to provide an alternative and effective treatment option for women diagnosed with early stage breast cancer.
About Ogden Regional Medical Center
This 238-bed hospital features a Level II Trauma Center and is Certified Primary Stroke Center as well as an accredited Chest Pain Center. Its caregivers earned an “A” Hospital Safety Score in the Spring 2016 update from the Leapfrog Group for the third consecutive time. It is the only hospital in Utah to earn the Coronary Intervention Excellence Award™ for two years in a row (2014 & 2015) from Healthgrades. Ogden Regional also achieved the Get With The Guidelines® - Stroke Gold Plus Award from the American Stroke in 2015. Ogden Regional Medical Center.
Phone: (801) 479-2591